October 31, 2013 / 11:16 AM / 4 years ago

Smith & Nephew picks new chairman as wound care boosts sales

LONDON, Oct 31 (Reuters) - Strong sales of wound care products helped Smith & Nephew grow revenue by an underlying 5 percent in the third quarter, while sales of artificial hips and knees improved after recent slow growth.

The British company also appointed Roberto Quarta as a non-executive director and chairman elect.

Smith & Nephew has been trailing rivals like Johnson & Johnson, Zimmer and Stryker in orthopaedic reconstruction due to a relative lack of new products.

The group posted revenue of $1.03 billion and adjusted earnings per share (EPSA) of 17.1 cents on Thursday, while trading profit rose 10 percent to $222 million.

Analysts, on average, had forecast revenue of $1.02 billion and EPSA of 17 cents, according to Thomson Reuters.

Smith & Nephew maintained its outlook for the full year but said market conditions remained tough.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below